Gene therapy for lysosomal storage disorders

被引:25
作者
Gritti, Angela [1 ]
机构
[1] Ist Sci San Raffaele, San Raffaele Telethon Inst Gene Therapy HSR TIGET, I-20132 Milan, Italy
关键词
CNS; gene delivery; gene therapy; lysosomal storage disorders; viral vectors; NEURAL STEM-CELLS; CENTRAL-NERVOUS-SYSTEM; ADENOASSOCIATED VIRUS VECTOR; ENZYME REPLACEMENT THERAPY; BONE-MARROW-TRANSPLANTATION; NONHUMAN PRIMATE BRAIN; MOUSE MODEL; LONG-TERM; LENTIVIRAL VECTORS; IMMUNE-RESPONSES;
D O I
10.1517/14712598.2011.582036
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Areas covered: Based on an extensive literature search up until March 2011, the author reviews and discusses the progress, the crucial aspects and the major challenges towards the development of novel gene therapy strategies aimed to target the CNS, with particular attention to direct intracerebral gene delivery and transplantation of neural stem/progenitor cells. Expert opinion: The implementation of viral vector delivery systems with specific tropism, regulated transgene expression, low immunogenicity and low genotoxic risk and the improvement in isolation and manipulation of relevant cell types to be transplanted, are fundamental challenges to the field. Also, combinatorial strategies might be required to achieve full correction in LSDs with neurological involvement.
引用
收藏
页码:1153 / 1167
页数:15
相关论文
共 178 条
  • [1] Stability of lentiviral vector-mediated transgene expression in the brain in the presence of systemic antivector immune responses
    Abordo-Adesida, E
    Follenzi, A
    Barcia, C
    Sciascia, S
    Castro, MG
    Naldini, L
    Lowenstein, PR
    [J]. HUMAN GENE THERAPY, 2005, 16 (06) : 741 - 751
  • [2] Transduction of neurons lining the cerebral external capsules in mice with feline immunodeficiency virus based vectors
    Alisky, JM
    Hughes, SM
    Davidson, BL
    [J]. NEUROSCIENCE LETTERS, 2003, 351 (02) : 120 - 124
  • [3] Lysosomal disorders: From storage to cellular damage
    Ballabio, Andrea
    Gieselmann, Volkmar
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2009, 1793 (04): : 684 - 696
  • [4] Emerging drugs for lysosomal storage diseases
    Beck, Michael
    [J]. EXPERT OPINION ON EMERGING DRUGS, 2010, 15 (03) : 495 - 507
  • [5] Correction of metachromatic leukodystrophy in the mouse model by transplantation of genetically modified hematopoietic stem cells
    Biffi, A
    De Palma, M
    Quattrini, A
    Del Carro, U
    Amadio, S
    Visigalli, I
    Sessa, M
    Fasano, S
    Brambilla, R
    Marchesini, S
    Bordignon, C
    Naldini, L
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2004, 113 (08) : 1118 - 1129
  • [6] Bischof D, 2010, METHODS MOL BIOL, V614, P53, DOI 10.1007/978-1-60761-533-0_3
  • [7] Long-term and significant correction of brain lesions in adult mucopolysaccharidosis type VII mice using recombinant AAV vectors
    Bosch, A
    Perret, E
    Desmaris, N
    Heard, JM
    [J]. MOLECULAR THERAPY, 2000, 1 (01) : 63 - 70
  • [8] Sorting of lysosomal proteins
    Braulke, Thomas
    Bonifacino, Juan S.
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2009, 1793 (04): : 605 - 614
  • [9] Complete correction of enzymatic deficiency and neurochemistry in the GM1-gangliosidosis mouse brain by neonatal adeno-associated virus-mediated gene delivery
    Broekman, M. L. D.
    Baek, R. C.
    Comer, L. A.
    Fernandez, J. L.
    Seyfried, T. N.
    Sena-Esteves, M.
    [J]. MOLECULAR THERAPY, 2007, 15 (01) : 30 - 37
  • [10] Mechanisms of distribution of mouse β-galactosidase in the adult GM1-gangliosidosis brain
    Broekman, M. L. D.
    Tierney, L. A.
    Benn, C.
    Chawla, P.
    Cha, J. H.
    Sena-Esteves, M.
    [J]. GENE THERAPY, 2009, 16 (02) : 303 - 308